- Home
- FTI vs SNN Comparison
FTI vs SNN Comparison
Compare FTI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTI | SNN |
|---|---|---|
| Founded | 1884 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | FTI | SNN |
|---|---|---|
| Price | $46.11 | $33.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $45.60 | $32.83 |
| AVG Volume (30 Days) | ★ 2.7M | 476.9K |
| Earning Date | 10-23-2025 | 03-02-2026 |
| Dividend Yield | 0.43% | ★ 2.19% |
| EPS Growth | 59.09 | ★ 59.91 |
| EPS | ★ 2.28 | 0.56 |
| Revenue | ★ $9,803,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | $10.34 | $7.78 |
| Revenue Next Year | $7.23 | $5.13 |
| P/E Ratio | ★ $20.18 | $29.10 |
| Revenue Growth | ★ 11.44 | 5.35 |
| 52 Week Low | $22.12 | $23.69 |
| 52 Week High | $47.33 | $38.79 |
Technical Indicators
Market Signals| Indicator | FTI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 67.50 | 48.01 |
| Support Level | $44.93 | $32.68 |
| Resistance Level | $47.33 | $33.56 |
| Average True Range (ATR) | 1.18 | 0.41 |
| MACD | 0.05 | 0.14 |
| Stochastic Oscillator | 74.85 | 78.51 |
Price Performance
Historical ComparisonAbout FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.